EcoDrugPlus

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma

Ensembl ID : ENSEEUG00000007607
Gene Symbol: PIK3CG
1 External references
215 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSEEUG00000008942
Gene Symbol: PDE3A
1 External references
258 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSEEUG00000008483
Gene Symbol: PDE4B
1 External references
298 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSEEUG00000001424
Gene Symbol: PDE4D
1 External references
235 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSEEUG00000008322
Gene Symbol: PDE5A
1 External references
208 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSEEUG00000003717
Gene Symbol: PDE7A
1 External references
240 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSEEUG00000002467
Gene Symbol: PIK3R3
1 External references
276 Possible Orthologues:

Phospholipase A2 Group V

Ensembl ID : ENSEEUG00000015150
Gene Symbol: PLA2G5
3 External references
116 Possible Orthologues:

Phospholipase A2 Group X

Ensembl ID : ENSEEUG00000010945
Gene Symbol: PLA2G10
1 External references
250 Possible Orthologues:

Phospholipase A2, Membrane Associated-Like

Ensembl ID : ENSEEUG00000006550
Gene Symbol: LOC103124103
2 External references
161 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase, Phosphoribosylglycinamide Synthetase, Phosphoribosylaminoimidazole Synthetase

Ensembl ID : ENSEEUG00000000317
Gene Symbol: GART
1 External references
247 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSEEUG00000013479
Gene Symbol: PTAFR
1 External references
224 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).